Daikaffil Chem (530825)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Loss is narrowing: profit growth of 5.56% and latest quarter net profit is near breakeven at -₹0 Cr.
• Piotroski F-Score of 5/9 shows some positive fundamental signals despite poor headline ratios.
• Book value of ₹17.73 per share provides a small tangible asset base.
• Still generating revenue of ₹1 Cr in the latest quarter, so the operating platform has not shut down.

Concerns

• ROE of -16.55% and ROCE of -18.57% indicate ongoing value destruction.
• Sales fell 58% and latest quarterly revenue is just ₹1 Cr, showing a sharply shrinking business.
• P/B of 7.55 with negative earnings makes the stock expensively priced relative to weak fundamentals.
• No dividend, unknown promoter holding, and unavailable debt/equity data reduce transparency and income support.

AI Analysis

Let me start with the obvious: this is not the kind of business I would normally spend a rupee on. At ₹133.95, the market is asking me to pay over 7.5 times book value for a company earning -16.55% on equity and -18.57% on capital. Every rupee retained in this business appears to be shrinking, not growing, in value. The price-to-earnings ratio is meaningless because there is no meaningful earnings power; the latest quarter net profit is essentially ₹0 Cr, and sales have collapsed by 58% to just ₹1 Cr. A business with that revenue size and no profit cannot give me a margin of safety at a ₹82 Cr market cap. I also see no moat here; a product line with falling sales and negative returns signals weak pricing power or weak demand. There are a few green shoots: profit growth of 5.56% suggests the loss is narrowing, and a Piotroski score of 5/9 is not a disaster. But when the base itself is a shrinking, loss-making specialty chemical micro-cap, those small improvements do not justify a 52-week range that has swung from ₹29.97 to ₹169.90. The stock currently sits far closer to the top than the bottom, which smells like speculation, not sober valuation. I also see no dividend, an unknown promoter holding, and no debt/equity data. I cannot judge who controls the company or how much leverage is buried in the balance sheet. Book value of ₹17.73 offers some asset support, but at 7.55 times book, that support is too far away to matter. If this is a turnaround, it is still unproven. I need to see sales stabilise, positive net profit, and returns on capital heading above zero before I would even consider this. Until then, I would rather watch from the sidelines.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer